Biomarkers

Blood-based Gene Expression Signatures of Infants and Toddlers with Autism.

Source: 
Journal of the American Academy of Child and Adolescent Psychiatry
Date Published: 
September 2012
Abstract: 

"OBJECTIVE: Autism spectrum disorders (ASDs) are highly heritable neurodevelopmental disorders that onset clinically during the first years of life. ASD risk biomarkers expressed early in life could significantly impact diagnosis and treatment, but no transcriptome-wide biomarker classifiers derived from fresh blood samples from children with autism have yet emerged.

RESULTS: Potential ASD biomarkers were discovered in one-half of the sample and used to build a classifier, with high diagnostic accuracy in the remaining half of the sample."

Biomarker Progress Offers Hope for Early Autism Spectrum Disorder Detection

Source: 
Science Daily
Date Published: 
November 30, 2012
Abstract: 

A special issue of Disease Markers offers a comprehensive review on how current genetic research can be applied to biomarker development in ASD.

Study Finds No Link Between Autism and Gut Microbes

Source: 
SFARI
Date Published: 
November 5, 2012
Abstract: 

Contradicting a popular hypothesis in autism, a new study from Australia has found no connection between autism and bacteria in the gut. For the peer-reviewed article, click here: http://www.ncbi.nlm.nih.gov/pubmed/22997101

Atypical Activation During the Embedded Figures Task as a Functional Magnetic Resonance Imaging Endophenotype of Autism

Source: 
Brain
Date Published: 
October 11, 2012
Abstract: 

This study uncovers a possible fMRI endophenotype of autism, showing that compared to typically developing controls with no family history of ASD, adolescents with autism and non-autistic siblings had atypical patterns of brain activation during the Embedded Figures Task.

The Emerging Biology of Autism Spectrum Disorders

Source: 
Science
Date Published: 
September 14, 2012
Abstract: 

Autism spectrum disorders (ASD) are a genetically and phenotypically heterogeneous group of syndromes defined by fundamental impairments in social reciprocity and language development accompanied by highly restrictive interests and/or repetitive behaviors. Recent advances in genetics, genomics, developmental neurobiology, systems biology, monogenic neurodevelopment syndromes, and induced pluripotent stem cells (iPSC) are now offering remarkable insights into their etiologies and converging to provide a clear and immediate path forward from the bench to the bedside.

Molecular mechanisms: Autism gene regulates neuron shape

Source: 
Simons Foundation Austism Research Initiative
Date Published: 
July 31,2012
Abstract: 

Scientists at MIT have found that TAOK2, a gene in the autism-associated chromosomal region, is part of a signaling pathway that builds neuronal connections during development.

Simple worms could help unravel complex human brains

Source: 
Simons Foundation Austism Research Initiative
Date Published: 
July 25,2012
Abstract: 

The nematode "Caenorhabditis elegans" may serve as a useful model to study synapses, the junctions between neurons.

Cognition and behavior: Fragile X carriers show autism signs

Source: 
Simons Foundation Austism Research Initiative
Date Published: 
July 27,2012
Abstract: 

According to a study published in the American Journal of Medical Genetics, Women who have a milder version of the fragile X mutation, which can lead to the full mutation in their children, have some features of autism.

Vanderbilt University Researchers Examine Oxytocin and Serotonin Systems as Biomarkers for Autism

Source: 
http://www.ncbi.nlm.nih.gov/pubmed/22721594.1
Date Published: 
May 26, 2012
Abstract: 

Vanderbilt University researchers examine oxytocin and serotonin systems as biomarkers for autism spectrum disorders.

Newly Published Genetics/Brain Tissue Study Will Help Refine the Search for Specific Early Genetic Markers of Risk of Autism in Babies and Toddlers

Source: 
PLoS Genetics
Date Published: 
March 22, 2012
Year Published: 
2012
Abstract: 

A new study of autism published today in PLoS Genetics has discovered abnormal gene activity and gene deletions in the same brain region that also has a 67% overabundance of brain cells. This region – the prefrontal cortex—is involved in social, emotional, communication and language skills. The finding brings new understanding of what early genetic abnormalities lead to excess brain cells and to the abnormal brain wiring that cause core symptoms in autism. Importantly, the study also shows that gene activity abnormalities in autism change across the lifespan.

By Dr. Eric Courchesne

A new study of autism published today in PLoS Genetics (Age Dependent Brain Gene Expression and Copy Number Anomalies in Autism Suggest Distinct Pathological Processes at Young Versus Mature Ages) has discovered abnormal gene activity and gene deletions in the same brain region that also has a 67% overabundance of brain cells.  This region – the prefrontal cortex—is involved in social, emotional, communication and language skills. The finding brings new understanding of what early genetic abnormalities lead to excess brain cells and to the abnormal brain wiring that cause core symptoms in autism. Importantly, the study also shows that gene activity abnormalities in autism change across the lifespan.

The research is one of the first to focus on gene activity inside the young autistic brain, and is the first to examine how gene expression activity changes across the lifespan in autism.  It is also one of the largest postmortem studies of autism to date. This close-up look inside the brain uncovered the presence of abnormal levels of activity in genes (“gene expression”) and gene defects (deletions of portions of DNA sequences) that control the number of brain cells and their growth and pattern of organization in the developing prefrontal cortex. The abnormal gene activity occurred in several networks that are important during prenatal brain development (cell cycle, neurogenesis, DNA damage detection and response, apoptosis and survival networks). This seems to rule out a number of current speculations about postnatal causes of autism and, combined with the new evidence of a 67% excess of prefrontal brain cells, points instead to prenatal causal events in a majority of cases.

The study’s direct examination of both mRNA and DNA from the same frontal cortex region in each individual is also a unique approach to discovering the genetics of abnormal brain development in autism.  The combined mRNA and DNA results indicate that a large and heterogeneous array of gene and gene expression defects disrupt prenatal processes that are critical to early prefrontal cortex formation. “Although DNA defects vary from autistic case to case, the diverse genetic deletions seem to underlie a relatively common biological theme, hitting a shared set of gene pathways that impact cell cycle, DNA damage detection and repair, migration, neural patterning and cell differentiation,” according to the study.  Importantly, the set of functional gene pathways identified by the study’s direct analyses of autistic brain tissue are consistent with those identified by previous studies that analyzed copy number variations in living autistic patients.

A second major discovery in this study is that the pattern of abnormal gene activity changes across the lifespan in autism. Thus, in adults with autism, the study found abnormal activity in genes involved in remodeling, repair, immune response and signaling. This raises opportunities for new research directions that ask whether and how such later alterations in genetic activity impact brain structure and function.  A hope is that perhaps this later, second stage of unusual genetic activity we detected in adults with autism has something to do with enhancing adaptive connections and pruning back earlier maladaptive connections.  Further research needs to better understand the impact of those later changes in genetic activity.

Findings in the new study will help refine the search for specific early genetic markers of risk of autism in babies and toddlers.  Next steps include identifying what causes the altered genetic activity at early stages of development, when nerve cells in prefrontal cortex arise and the first steps in creating brain circuitry are being taken.  Knowledge of these specific patterns of abnormal gene activity may also give rise to future studies that search for medical interventions that target abnormal gene activity in an age-specific fashion.